
Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Lead Product(s) : Undisclosed
Therapeutic Area : Technology
Study Phase : Discovery Platform
Recipient : Invenra
Deal Size : Undisclosed
Deal Type : Collaboration
Invenra and Xcellon Collaborate on Bispecific and Trispecific ADC Development
Details : The collaboration aims to advance the development of an undisclosed antibody-drug conjugate in an undisclosed target area.
Product Name : Undisclosed
Product Type : Antibody-drug Conjugate
Upfront Cash : Undisclosed
October 22, 2025
Lead Product(s) : Undisclosed
Therapeutic Area : Technology
Highest Development Status : Discovery Platform
Recipient : Invenra
Deal Size : Undisclosed
Deal Type : Collaboration
